Emergex Update - March 2021

Dear Shareholders,

Emergex is pleased to announce that Swiss Medic has approved entry into the clinic for a Phase I safety trial in humans.

We will keep you appraised of further progress.

If you have any questions, please email Storme smt@emergexvaccines.com

Would you like to know more?

If you feel your business could benefit from our knowledge and expertise, use the form below to contact us and one of our experts will be in touch.